S0 BROOKLAX Senna Laxative Chocolate. Reg. No. 35/11.5/0168. Each chocolate tablet contains 30 mg Sennoside A and B as calcium salts. S0 BROOKLAX Bisacodyl Laxative Pills (enteric-coated tablets). Reg. No.: 36/11.5/0104. Each enteric-coated tablet contains Bisacodyl 5 mg. S0 LACSON. Reg. No.: Z/11.5/0055. Each 5 ml of syrup contains 3,3 g of lactulose. S0 GASTROPECT. Reg. No.: E/11.9/1546. Each 5 ml suspension contains light kaolin 1,00 g and pectin 0,05 g. S0 HAMBURG Tea. Reg. No.: E/11.5/0704. Each 5 ml medicine measure contains: 537,5 mg senna leaves which is equivalent to 13,4 mg, hydroxyanthracene glycosides as sennoside B. S0 LENOLAX. Reg. No.: E/11.5/819. Each 1ml contains sodium dihydrogen phosphate dihydrate equivalent to 160 mg sodium dihydrogen phosphate monohydrate and disodium phosphate dodecahydrate equivalent to 60 mg disodium phosphate heptahydrate. S0 LENOLAX Paediatric. Reg. No.: E/11.5/1982. Each 1ml contains sodium dihydrogen phosphate dihydrate equivalent to 160 mg sodium dihydrogen phosphate monohydrate and disodium phosphate dodecahydrate equivalent to 60 mg disodium phosphate heptahydrate. S0 LENNON Glycerin Suppositories For Adults. Reg. No.: E/11.6/1495. Each suppository contains 2,14 g glycerin. S0 LENNON Glycerin Suppositories For Infants And Children. Reg. No.: E/11.6/1540. Each suppository contains 1,12 g glycerin. S0 GERMOLENE Ointment. Ref. No.:G1847 (Act 101/1965). Each 100 g contains anhydrous lanolin 38,716 g, maize starch 7,840 g, zinc oxide 7,840 g, methyl salicylate 2,960 g, phenol 1,184 g, octaphonium chloride 0,300 g, menthol 0,012 g. S0 PREP Cream Ref. No.: G1529 (Act 101/1965). Each 100 g contains: Borax 1,043 g, Camphor 720,8 mg, Phenol 213,0 mg, Menthol Levo 128,0 mg, Thymol 41,584 mg and Clove oil 0,042 ml. Trademarks are owned by or licensed to the Aspen Group of companies. © 2023 Aspen Group of companies or its licensor. All rights reserved. Marketed by Pharmacare Limited t/a Aspen Pharmacare Co. Reg. No.: 1898/000252/06. Healthcare Park, Woodlands Drive, Woodmead, 2191.
ZAR-BIS-02-23-00005 03/2023